Both TSP50 and MMP9 are aberrantly expressed in human breast cancer tissues, and here we found TSP50 overexpression promoted MMP9 expression through NF-κB signaling pathway, therefore, we examined the correlation of TSP50 with p65 and MMP9 in human breast cancer clinical samples. Here, PRSS50 is linked to breast cancer.